feed,title,long_url,short_url
MedRxiv,"SARS-CoV-2 hyperimmune globulin for severely immunocompromised patients with COVID-19: a randomised, controlled, double-blind, phase 3 trial",https://medrxiv.org/cgi/content/short/2022.04.04.22273314v1?rss=1,https://bit.ly/3r6pFKG
MedRxiv,Safety and Efficacy of Dupilumab for the Treatment of Hospitalized Patients with Moderate to Severe COVID 19: A Phase IIa Trial,https://medrxiv.org/cgi/content/short/2022.03.30.22273194v1?rss=1,https://bit.ly/3uPR5Wc
MedRxiv,Real-World Evidence of the Neutralizing Monoclonal Antibody Sotrovimab for Preventing Hospitalization and Mortality in COVID-19 Outpatients,https://medrxiv.org/cgi/content/short/2022.04.03.22273360v1?rss=1,https://bit.ly/35H82cW
